Studies: AIMS2 Study

Title

AIMS2 Study 

Body

This study examines the effectiveness of a new medication for improving cognitive functioning over six months.


In order to participate, you must be:

between 18-59 years

have a definite diagnosis of MS

experience cognitive difficulties




Please call us and our Clinical Research Coordinator, Patricia Melville, RN, is happy to tell you more!

631-444-8164

Expires

 

MS Category

Adult 

Investigator

Dr. Lauren Krupp, MD 
Attachments
Created at 10/8/2007 12:48 PM  by SPHINX\Administrator 
Last modified at 10/8/2007 12:48 PM  by SPHINX\Administrator 
Home | Disclaimer | Privacy Notice
 Copyright National Pediatric MS Center @ Stony Brook University